P409 Study of epidemiology, risk factors and antifungal sensitivity pattern of fungal pneumonia in critically ill cirrhotics

IF 1.9 Q4 MYCOLOGY
Paras Singh, P. Kale, V. Khillan, S. Sarin
{"title":"P409 Study of epidemiology, risk factors and antifungal sensitivity pattern of fungal pneumonia in critically ill cirrhotics","authors":"Paras Singh, P. Kale, V. Khillan, S. Sarin","doi":"10.1093/mmy/myac072.P409","DOIUrl":null,"url":null,"abstract":"Abstract Poster session 3, September 23, 2022, 12:30 PM - 1:30 PM Objectives Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studied the epidemiology and risk factors, and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics. Methods Single-center, prospective cohort study of 100 critically ill cirrhotics with fungal pneumonia between January to September 2021. Comparative analysis was done for culture, realtime PCR and biomarkers, bronchoalveolar lavage and serum Galactomannan, and serum procalcitonin measured on days 1, 3, and 7. The final outcome considered was mortality within 1 month after diagnosis or discharge. Results Aspergillus flavus was the most common species (70/100,70%). Risk factors were, neutropenia (P .03), steroids prior to ICU admission (P .02), prolonged hospitalizations ˃21 days (P .05), and culture positivity was 80%. The culture was not inferior to realtime PCR for the diagnosis of fungal pneumonia. BAL Galactomannan was an early prognostic marker with a median rise above ˃ 3.5 index value. The Median PCT level was higher from day 1in the fungal pneumonia non-survivor group (3.29 vs. 0.8 ng/ml) with higher 30-day mortality (72%). Higher PCT was associated with bacterial co-infection (48%), antibiotic (74%), antifungal therapy, and renal failure and mortality. Conclusion Fungal pneumonia complicates cirrhotics with neutropenia, prolonged hospitalization, and steroids as risk factors. Aspergillus flavus predominate in consensus with Asian epidemiology. Culture methods are reliable and a combination of molecular tests with BAL Galactomannan is useful for rapid diagnosis. Serum PCT is raised in patients with fungal pneumonia and is associated with higher mortality. In our study the baseline PCT at admission to ICU was higher in the non-survivor group, and levels on D3 and D7 were persistently higher. High serum procalcitonin level is an independent prognostic biomarker of mortality risk in fungal pneumonia.","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"15 1","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/mmy/myac072.P409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Poster session 3, September 23, 2022, 12:30 PM - 1:30 PM Objectives Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studied the epidemiology and risk factors, and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics. Methods Single-center, prospective cohort study of 100 critically ill cirrhotics with fungal pneumonia between January to September 2021. Comparative analysis was done for culture, realtime PCR and biomarkers, bronchoalveolar lavage and serum Galactomannan, and serum procalcitonin measured on days 1, 3, and 7. The final outcome considered was mortality within 1 month after diagnosis or discharge. Results Aspergillus flavus was the most common species (70/100,70%). Risk factors were, neutropenia (P .03), steroids prior to ICU admission (P .02), prolonged hospitalizations ˃21 days (P .05), and culture positivity was 80%. The culture was not inferior to realtime PCR for the diagnosis of fungal pneumonia. BAL Galactomannan was an early prognostic marker with a median rise above ˃ 3.5 index value. The Median PCT level was higher from day 1in the fungal pneumonia non-survivor group (3.29 vs. 0.8 ng/ml) with higher 30-day mortality (72%). Higher PCT was associated with bacterial co-infection (48%), antibiotic (74%), antifungal therapy, and renal failure and mortality. Conclusion Fungal pneumonia complicates cirrhotics with neutropenia, prolonged hospitalization, and steroids as risk factors. Aspergillus flavus predominate in consensus with Asian epidemiology. Culture methods are reliable and a combination of molecular tests with BAL Galactomannan is useful for rapid diagnosis. Serum PCT is raised in patients with fungal pneumonia and is associated with higher mortality. In our study the baseline PCT at admission to ICU was higher in the non-survivor group, and levels on D3 and D7 were persistently higher. High serum procalcitonin level is an independent prognostic biomarker of mortality risk in fungal pneumonia.
重症肝硬化真菌性肺炎流行病学、危险因素及抗真菌敏感性研究
摘要:2022年9月23日,下午12:30 - 1:30,海报3目的肝硬化导致免疫失调,增加对真菌感染的易感性。我们研究了真菌性肺炎的流行病学和危险因素,并比较了重症肝硬化真菌性肺炎的快速诊断方法和生物标志物。方法对2021年1月至9月期间100例重症肝硬化合并真菌性肺炎患者进行单中心前瞻性队列研究。比较分析第1、3和7天的培养、实时PCR和生物标志物、支气管肺泡灌洗和血清半乳甘露聚糖和血清降钙素原。考虑的最终结局是诊断或出院后1个月内的死亡率。结果黄曲霉是最常见的菌种(70/100,70%)。危险因素为中性粒细胞减少症(P .03)、入ICU前使用类固醇(P .02)、住院时间延长至21天(P .05)、培养阳性80%。培养对真菌性肺炎的诊断不逊于实时PCR。BAL半乳甘露聚糖为早期预后指标,中位数高于3.5指数值。真菌性肺炎非幸存者组的PCT中位数从第1天开始就较高(3.29 vs 0.8 ng/ml), 30天死亡率较高(72%)。较高的PCT与细菌合并感染(48%)、抗生素(74%)、抗真菌治疗、肾功能衰竭和死亡率相关。结论真菌性肺炎并发肝硬化伴中性粒细胞减少、住院时间延长和类固醇是危险因素。与亚洲流行病学一致,黄曲霉占主导地位。培养方法可靠,分子试验与BAL半乳甘露聚糖结合可用于快速诊断。真菌性肺炎患者血清PCT升高,并与较高的死亡率相关。在我们的研究中,非幸存者组入院时的基线PCT较高,D3和D7水平持续较高。高血清降钙素原水平是真菌性肺炎死亡风险的独立预后生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical mycology journal
Medical mycology journal Medicine-Infectious Diseases
CiteScore
1.80
自引率
10.00%
发文量
16
期刊介绍: The Medical Mycology Journal is published by and is the official organ of the Japanese Society for Medical Mycology. The Journal publishes original papers, reviews, and brief reports on topics related to medical and veterinary mycology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信